Poster # 2270 Borderline Resectable Pancreatic Adenocarcinoma: Tumor Volume and CA19-9 Reduction Following Neoadjuvant Chemotherapy and Fractionated Stereotactic Body Radiotherapy Correlates with Pathologic Response

Presenter: Chi Lin, MD, PhD

Contact the presenter at: clin@unmc.edu



 View the poster



E-mail a friend about this poster:
Enter email address: